These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 21575504)
1. [Effecacy of three-dimensional conformal radiation therapy combined with Tegafur for postoperative recurrent rectal carcinoma]. Liu XH; Li WL Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):299-301. PubMed ID: 21575504 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. Atasoy BM; Abacioglu U; Dane F; Ozgen Z; Yumuk PF; Ozden S; Akgun Z; Mayadagli A; Basaran G; Turhal S; Sengoz M J BUON; 2007; 12(2):203-8. PubMed ID: 17600873 [TBL] [Abstract][Full Text] [Related]
4. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial. Pfeiffer P Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693 [TBL] [Abstract][Full Text] [Related]
5. [Effecting observation of 3-dimensional conformal radiotherapy combined with chemotherapy for rectal cancer of postoperative local recurrence]. Wu DH; Chen LH Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):901-3. PubMed ID: 15363248 [TBL] [Abstract][Full Text] [Related]
6. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC). Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002 [TBL] [Abstract][Full Text] [Related]
7. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens. Klenova A; Parvanova V; Georgiev R; Gesheva N J BUON; 2006; 11(2):161-6. PubMed ID: 17318965 [TBL] [Abstract][Full Text] [Related]
8. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D; Kyau-Ummen B; Halbfass HJ Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [TBL] [Abstract][Full Text] [Related]
9. Preoperative tegafur suppositories for resectable rectal cancer: phase II trial. Ohwada S; Sato Y; Izumi M; Kashiwabara K; Ogawa T; Hamada K; Kawate S; Nakamura S Dis Colon Rectum; 2006 Oct; 49(10):1602-10. PubMed ID: 17036208 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661 [TBL] [Abstract][Full Text] [Related]
12. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
13. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780 [TBL] [Abstract][Full Text] [Related]
14. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost. Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396 [TBL] [Abstract][Full Text] [Related]
17. Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer. Milani V; Pazos M; Issels RD; Buecklein V; Rahman S; Tschoep K; Schaffer P; Wilkowski R; Duehmke E; Schaffer M Strahlenther Onkol; 2008 Mar; 184(3):163-8. PubMed ID: 18330513 [TBL] [Abstract][Full Text] [Related]
18. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up. Fernández-Martos C; Aparicio J; Bosch C; Torregrosa M; Campos JM; Garcera S; Vicent JM; Maestu I; Climent MA; Mengual JL; Tormo A; Hernandez A; Estevan R; Richart JM; Viciano V; Uribe N; Campos J; Puchades R; Arlandis F; Almenar D J Clin Oncol; 2004 Aug; 22(15):3016-22. PubMed ID: 15210740 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393 [TBL] [Abstract][Full Text] [Related]
20. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer]. Wang J; Pang QS; Wang P; Wang J; Wang W Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]